Clinical Trial Update: Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic Retinopathy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating perfluorocarbon perfused vitrectomy and a 3D vitrectomy system for advanced diabetic retinopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diabetic Retinopathy | Phase 3 | Status: WITHDRAWN